Sirna Therapeutics News
Most Popular Sirna Therapeutics Story
Alnylam, Merck dump RNAi deal
A little more than a year after revising their RNAi development deal to include $120 million in milestone payments, Read more...
Latest Headlines
- June 25, 2008
- October 17, 2007
- September 19, 2007
- July 19, 2007
- July 12, 2007
- July 8, 2007
- July 5, 2007
- January 8, 2007
- December 1, 2006
- November 15, 2006
- November 8, 2006
- November 7, 2006
- November 2, 2006
- November 1, 2006
- October 30, 2006
- August 15, 2006
- August 10, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
